Scarica l'app Stockscreener
4.18
0.72%
0.03
Dopo l'orario di chiusura:
4.15
-0.03
-0.72%
Precedente Chiudi:
$4.15
Aprire:
$4.23
Volume 24 ore:
1.43M
Relative Volume:
1.51
Capitalizzazione di mercato:
$237.99M
Reddito:
-
Utile/perdita netta:
$-82.44M
Rapporto P/E:
-2.2234
EPS:
-1.88
Flusso di cassa netto:
$-66.75M
1 W Prestazione:
-3.24%
1M Prestazione:
+31.86%
6M Prestazione:
+207.35%
1 anno Prestazione:
+22.94%
Intervallo 1D:
$4.07
$4.45
Intervallo di 1 settimana:
$3.69
$4.45
Portata 52W:
$1.195
$4.45
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Nome
Black Diamond Therapeutics Inc
Settore
Industria
Telefono
617-417-5868
Indirizzo
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Confronta BDTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
4.18 | 214.08M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | Guggenheim | Buy |
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2024-07-31 | Iniziato | Raymond James | Outperform |
| 2023-07-14 | Iniziato | Piper Sandler | Overweight |
| 2023-06-30 | Aggiornamento | Stifel | Hold → Buy |
| 2023-06-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-03-29 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-03-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | Iniziato | Stifel | Hold |
| 2021-01-07 | Iniziato | Wedbush | Outperform |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2020-02-24 | Iniziato | Canaccord Genuity | Buy |
| 2020-02-24 | Iniziato | Cowen | Outperform |
| 2020-02-24 | Iniziato | JP Morgan | Overweight |
| 2020-02-24 | Iniziato | Jefferies | Buy |
Mostra tutto
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
Will Black Diamond Therapeutics Inc. outperform the marketMarket Sentiment Report & Weekly Setup with High ROI Potential - newser.com
BDTX: Stifel Reinstates "Buy" Rating with an $8.00 Price Target | BDTX Stock News - GuruFocus
Black Diamond Therapeutics (BDTX): Promising Potential in Cancer Research - GuruFocus
How to use Fibonacci retracement on Black Diamond Therapeutics Inc.2025 Geopolitical Influence & Smart Money Movement Tracker - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockQuarterly Market Review & Community Consensus Trade Signals - newser.com
Can NSCLC Drug Silevertinib Drive Sustainable Growth for BDTX? - sharewise.com
Applying Elliott Wave Theory to Black Diamond Therapeutics Inc.July 2025 Sentiment & Fast Momentum Entry Tips - newser.com
Wealth Enhancement Advisory Services LLC Takes $28,000 Position in Black Diamond Therapeutics, Inc. $BDTX - Defense World
Published on: 2025-10-13 09:41:17 - newser.com
Using RSI to spot recovery in Black Diamond Therapeutics Inc.Jobs Report & Community Consensus Trade Signals - newser.com
Why Black Diamond Therapeutics Inc. is moving todayTrade Performance Summary & Verified Swing Trading Watchlists - newser.com
Black Diamond Therapeutics (BDTX): Valuation Insights After Surging Interest From Strong Earnings and Growth Momentum - Yahoo Finance
Black Diamond Therapeutics Inc Stock Analysis and ForecastPrice Momentum Alerts & Get Peace of Mind with Portfolio Health Checks - earlytimes.in
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - inkl
Black Diamond Therapeutics' (BDTX) Sell (D) Rating Reaffirmed at Weiss Ratings - MarketBeat
Black Diamond Therapeutics Hits New 52-Week High of $4.11 - Markets Mojo
Black Diamond Therapeutics Hits New 52-Week High at $4.03 - Markets Mojo
Black Diamond Therapeutics Hits New 52-Week High at $3.90 - Markets Mojo
BDTX Stock Hits 52 Week High: Is There More Room for Growth? - sharewise.com
How to escape a deep drawdown in Black Diamond Therapeutics Inc.2025 Market Overview & Risk Managed Trade Strategies - newser.com
Will Black Diamond Therapeutics Inc. stock recover faster than market2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Using Bollinger Bands to evaluate Black Diamond Therapeutics Inc.July 2025 Highlights & Free Long-Term Investment Growth Plans - newser.com
Black Diamond Therapeutics, Inc. (BDTX) Hit a 52 Week High, Can the Run Continue? - sharewise.com
Will Black Diamond Therapeutics Inc. stock benefit from infrastructure spendingQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Published on: 2025-10-05 06:35:20 - newser.com
Technical signs of recovery in Black Diamond Therapeutics Inc.July 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
Published on: 2025-10-03 07:14:35 - newser.com
Why analysts upgrade Black Diamond Therapeutics Inc. stockMarket Growth Summary & Community Consensus Picks - newser.com
Smart tools for monitoring Black Diamond Therapeutics Inc.’s price actionWeekly Volume Report & Daily Profit Focused Screening - newser.com
Published on: 2025-10-03 00:58:16 - newser.com
Published on: 2025-10-02 23:04:01 - newser.com
Visual trend scoring systems applied to Black Diamond Therapeutics Inc.July 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
Black Diamond Therapeutics (BDTX) Has a New Rating from Freedom Capital Markets - The Globe and Mail
Published on: 2025-10-01 08:07:11 - newser.com
Regression analysis insights on Black Diamond Therapeutics Inc. performance2025 Support & Resistance & Stock Market Timing Techniques - newser.com
Black Diamond Therapeutics stock initiated with Buy rating at Freedom Capital - Investing.com Canada
Promising Penny Stocks To Watch In September 2025 - Yahoo Finance
Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):